 Basilea Pharmaceutica Ltd SIX: BSLN, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today the ... Read Full Story at source may require registration The post Basilea reports preliminary 2022 revenues, exceeding guidance, and provides portfolio update appeared first on ForexTV... 